Department of Psychiatry and Behavioral Sciences

Study links ADHD pharmacotherapy and retention rates for substance use disorder treatment

Kristopher Kast, MD, assistant professor in the Department of Psychiatry and Behavioral Sciences and clinical director of Vanderbilt’s Addiction Consult Service, has discovered a strong association between attention-deficit/hyperactivity disorder (ADHD) pharmacotherapy and retention rates for substance use disorder (SUD) treatment.

New Clinician Spotlight: Aaron Brinen

Aaron Brinen, PsyD, has joined Vanderbilt University Medical Center from Drexel College of Medicine in Philadelphia. He began seeing patients on Oct. 1, 2020.

Youth with ASD have higher body mass index: study

Vanderbilt researchers have concluded that children with autism spectrum disorder (ASD) tend to have higher body mass index (BMI) percentiles when compared to youth with typical development.

Psychiatry lecture focuses on mental health disparities

On Friday, Feb. 5, the Department of Psychiatry and Behavioral Sciences hosted the third annual Harold Jordan Diversity and Inclusion Lecture featuring guest speaker Ruth Shim, MD, MPH, professor of Cultural Psychiatry and Clinical Psychiatry at the University of California, Davis.

Depression and the brain-age gap

Older depressed adults show accelerated brain aging, according to a new study from Vanderbilt researchers, who suggest that the effects of depression may speed the decline in cognitive functions in older individuals.

Study explores nicotine patch to treat late-life depression

Backed by nearly $5 million in funding, researchers from Vanderbilt University Medical Center are testing to see whether transdermal nicotine patches can improve mood, forgetfulness and attentiveness in adults over 60 with a diagnosis of depression.

1 2 3 4 5 6 12